Shares in Tooru PLC (AIM:TOO, FRA:73N) rose 12% to 0.21p after the health and wellness group reported its operating businesses are generating average monthly gross revenue of around £1 million and EBITDA of £150,000 in the first quarter of 2026.
The company, whose portfolio includes free-from food brands Juvela, OAF and Pulsin, said it expects those levels to increase through the year.
OAF, viewed by the board as a key near-term growth driver, has launched with Asda with initial sales ahead of expectations and is introducing new product lines into Tesco.
Pulsin has returned to growth with improved margins following new capital investment and a contract manufacturing arrangement.
Tooru is also progressing the potential acquisition of Mylky, exploring debt funding structures to complete a deal that would involve issuing shares at 0.77p, a significant premium to the current market price.
The board expects its subsidiaries to deliver a strong EBITDA performance for the 2025 financial year compared to the prior period.
Scott Livingston, chief executive, said the group is "seeing encouraging momentum" and is "well positioned to accelerate growth and continue building value across the portfolio".